Danaher Corp - Company Profile

Powered by

All the sales intelligence you need on Danaher Corp in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Danaher Corp fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Danaher Corp.

Back to companies

Danaher Corp: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Related keylists

View more

Danaher Corp (Danaher) is a science and technology company that conducts business in biotechnology, life sciences, and diagnostics. The company provides a wide range of testing instruments, medical diagnostic solutions, life science research tools, professional microscopes, reagents and mass spectrometry, genomic consumables, filtration and flow cytometry, genomics, lab automation, centrifugation, particle counting, and characterization businesses. Danaher offers its products and services to pharmaceutical and biotechnology companies, healthcare providers, and research institutions through independent distributors in the Americas, Europe, the Middle East, Africa, and Asia-Pacific. It has manufacturing facilities in Europe, Australia, Asia, and the Americas. Danaher is headquartered in Washington, DC, the US.

 Gain a 360-degree view of Danaher Corp and make more informed decisions for your business Gain a 360-degree view of Danaher Corp and make more informed decisions for your business Learn more
Headquarters United States of America
Address 2200 Pennsylvania Ave Nw Ste 800w, Washington, WashingtonD.C., 20037-1701
Website www.danaher.com
Telephone 1 202 8280850
No of Employees 58,000
Industry Medical Equipment
Ticker Symbol & Exchange DHR (NYSE)
Revenue (2024) $24.6B 2.9% (2024 vs 2023)
EPS XYZ
Net Income (2024) XYZ -7.3% (2024 vs 2023)
Market Cap* $134.8B
Net Profit Margin (2024) XYZ -9.9% (2024 vs 2023)
* As of and is in US$
View Danaher Corp financials
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Danaher Corp premium industry data and analytics

300+

Medical Clinical Trials

A database of clinical trials planned, currently ongoing, completed, suspended, withdrawn, and terminated in countries around the world.

280+

Medical Pipeline Products

A database of medical devices that are in the process to get approved for sale around the world. Devices that are in development, through to those in the approval process are included.

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Danaher Corp’s likely spend across technology areas enabling you to understand the digital strategy.

Products and Services

Products Services Brands
Clinical Instruments Remote Monitoring Service Cytiva
Reagents Hospital and Laboratory Services Pall
Software Abcam
XYZ XYZ
XYZ XYZ
XYZ XYZ
Understand Danaher Corp portfolio and identify potential areas for collaboration Understand Danaher Corp portfolio and identify potential areas for collaboration Learn more

History

History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.

Year Event Description
2026 Acquisitions/Mergers/Takeovers In June, the company acquired Masimo Corporation, a specialty diagnostics provider of pulse oximetry and other patient monitoring solutions.
2026 Contracts/Agreements In March, Cytiva signed a FlexFactory agreement with Yoshindo to develop single-use biomanufacturing capabilities in Toyama.
2026 Regulatory Approval In March, Mammotome secured FDA clearance for its in-room Prima MR dual vacuum-assisted breast biopsy system and HydroMARK Plus MR biopsy site markers.
Dive into past operations, including product releases, deals, acquisitions & more Dive into past operations, including product releases, deals, acquisitions & more Learn more
Image for loader

Competitor Comparison

Key Parameters Danaher Corp Johnson & Johnson Eli Lilly and Co Merck & Co Inc AbbVie Inc
Headquarters United States of America United States of America United States of America United States of America United States of America
City Washington New Brunswick Indianapolis Rahway North Chicago
State/Province WashingtonD.C. New Jersey Indiana New Jersey Illinois
No. of Employees 58,000 138,200 50,605 75,000 57,000
Entity Type Public Public Public Public Public
Benchmark the company against the market with exclusive information on key competitors Benchmark the company against the market with exclusive information on key competitors Learn more
Chart Financial activity with access to more key stats Chart Financial activity with access to more key stats Learn more
Executives
Name Position Board Since Age
Rainer M. Blair Chief Executive Officer; President; Director Executive Board 2020 61
Mitchell P. Rales Co-Chairman Executive Board 1984 69
Steven M. Rales Co-Chairman Executive Board 1984 74
Matthew Gugino Chief Financial Officer Senior Management 2026 -
Jose-Carlos Gutierrez-Ramos Senior Vice President; Chief Scientific Officer Senior Management 2020 63
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Danaher Corp key executives to enhance your sales strategy Gain insight into Danaher Corp key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?